Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
XYL — Xylem Inc.
NYSE
FULL STOCK PAGE →

Summary of Xylem's Q3 2025 Earnings Call

OCT 28, 2025 2 MIN READ
REVENUE
$2.27B -1.4%
NET MARGIN
10.0% +0.2 PTS
EPS
$0.93 0.0%
FREE CASH FLOW
$281.0M +35.7%

1Key Financial Results and Metrics

Revenue Growth: Xylem reported a 7% revenue increase in Q3 2025, driven by strong performance in Measurement and Control Solutions (MCS) and Water Solutions and Services (WSS).

EBITDA Margin: Achieved a record EBITDA margin of over 23%, expanding 200 basis points year-over-year.

Earnings Per Share (EPS): EPS grew by 23% to $1.37.

Orders: Orders were down 2% year-over-year, attributed to tough comparisons, particularly in China, but the backlog remained robust at approximately $5 billion.

Free Cash Flow: Year-to-date free cash flow was slightly down due to restructuring payments and outsourced projects, but net debt to adjusted EBITDA stood at a strong 0.4x.

2Strategic Updates and Business Highlights

Divestiture: Announced the sale of its international metering business for $125 million, expected to close in early 2026, which will improve MCS segment margins by 100 basis points on a run-rate basis.

80/20 Initiative: Continued implementation of the 80/20 strategy is driving operational improvements and resource allocation towards high-value opportunities, with 80% of the business in some phase of implementation.

Customer Engagement: Highlighted successful partnerships, including a project with Amazon to enhance water management in Mexico City, showcasing Xylem's commitment to digital water solutions.

3Forward Guidance and Outlook

Revenue Guidance: Raised full-year revenue guidance to approximately $9 billion, reflecting 5% to 6% total growth and 4% to 5% organic growth.

EBITDA Margin Guidance: Updated EBITDA margin expectations to 22% to 22.3%, up from previous estimates, due to accelerated restructuring and simplification efforts.

EPS Guidance: Increased EPS forecast to $5.03 to $5.08.

Q4 Expectations: Anticipates revenue of about $2.4 billion with 2% to 3% organic growth and an EBITDA margin of roughly 23%.

4Bad News, Challenges, or Points of Concern

Order Decline: Orders were down 2% in Q3, with significant softness in China impacting overall performance.

Government Shutdown: Potential delays in federal funding could affect project timelines, although no immediate impact was reported.

China Market: Facing challenges, Xylem is restructuring its operations in China, reducing the workforce by 40% due to declining demand and competitive pressures.

Tariff Impacts: Updated annualized tariff impact estimated at $180 million, with a slight margin dilutive effect expected.

5Notable Q&A Insights

Future Margin Improvements: Management expressed confidence in achieving further margin improvements beyond current targets, with ongoing operational enhancements.

MCS Segment Outlook: Strong demand in the MCS segment, particularly for AMI solutions, is expected to support growth into 2026 despite current order trends.

Government Funding: Management indicated that previously allocated funds would continue to support projects despite potential delays from the government shutdown.

Long-term Strategy: Emphasis on focusing resources on core competencies and strategic acquisitions, with a disciplined approach to M&A and share buybacks. Overall, Xylem's Q3 2025 results reflect strong operational execution and strategic focus, despite facing challenges in certain markets, particularly China. The company is well-positioned for continued growth with an optimistic outlook for the remainder of the year.

SOURCE: Q3 2025 EARNINGS CALL TRANSCRIPT